Literature DB >> 4269383

Purification of exfoliatin produced by Staphylococcus aureus of bacteriophage group 2 and its physicochemical properties.

I Kondo, S Sakurai, Y Sarai.   

Abstract

An effective method for the isolation and purification of exfoliatin which has been recently reported by Melish and others as the staphylococcal toxin responsible for the scalded skin syndrome and the physicochemical properties of the purified toxin were described. From an active crude toxin produced by one of the clinical isolates of phage group 2, four types of toxic proteins which were all capable of causing the typical Nikolsky sign in neonatal mice were obtained and designated A, B, C, and D toxins. They had a molecular weight of about 24,000 and showed the same serological features in neutralization and precipitation tests, but were different from each other in showing a different single band with their respective mobilities in polyacrylamide disk electrophoresis. They were precipitated between pH 4.0 and 4.5 and lost their exfoliative capabilities. The resulting precipitates, however, could be solubilized in acetate buffer containing 0.5% sodium dodecyl sulfate, restoring their toxicities to almost the same extent as before. They were all stable when heated at 60 C for 60 min and at 100 C for 20 min, but lost their toxicities when heated at 100 C for 40 min. Additionally, the present authors observed that some staphylococcal strains not belonging to the typical phage group 2, isolated from patients with the scalded skin syndrome, were also capable of producing a similar but serologically unrelated exfoliative toxin.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4269383      PMCID: PMC422827          DOI: 10.1128/iai.8.2.156-164.1973

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  13 in total

1.  DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS.

Authors:  B J DAVIS
Journal:  Ann N Y Acad Sci       Date:  1964-12-28       Impact factor: 5.691

2.  Purification and properties of staphylococcal delta hemolysin.

Authors:  A S Kreger; K S Kim; F Zaboretzky; A W Bernheimer
Journal:  Infect Immun       Date:  1971-03       Impact factor: 3.441

3.  [Toxic epidermal necrolysis. The scald-syndrome].

Authors:  A Holzel; S I Jacobs
Journal:  Schweiz Med Wochenschr       Date:  1966-04-02

4.  Toxic epidermal necrolysis (the scalded skin syndrome). Its association in two cases with pathogenic staphylococci and its similarity in infancy to Ritter's disease.

Authors:  R G Tyson; S C Ushinski; R Kisilevsky
Journal:  Am J Dis Child       Date:  1966-04

5.  The staphylococcal scalded-skin syndrome.

Authors:  M E Melish; L A Glasgow
Journal:  N Engl J Med       Date:  1970-05-14       Impact factor: 91.245

6.  Outbreak of toxic epidermal necrolysis associated with staphylococci.

Authors:  A Lyell; H M Dick; J O Alexander
Journal:  Lancet       Date:  1969-04-19       Impact factor: 79.321

7.  Product of Staphylococcus aureus responsible for the scalded-skin syndrome.

Authors:  F A Kapral; M M Miller
Journal:  Infect Immun       Date:  1971-11       Impact factor: 3.441

8.  The scalded skin syndrome in small children.

Authors:  E D Lowney; J V Baublis; G M Kreye; E R Harrell; A R McKenzie
Journal:  Arch Dermatol       Date:  1967-04

9.  A review of toxic epidermal necrolysis in Britain.

Authors:  A Lyell
Journal:  Br J Dermatol       Date:  1967-12       Impact factor: 9.302

10.  Toxic epidermal necrolysis. A report of 42 cases.

Authors:  M J Samuels
Journal:  Br J Dermatol       Date:  1967-12       Impact factor: 9.302

View more
  32 in total

1.  Cloning of the gene coding for Staphylococcus hyicus exfoliative toxin B and its expression in Escherichia coli.

Authors:  T Watanabe; H Sato; Y Hatakeyama; T Matsuzawa; M Kawai; C Aizawa; H Danbara; N Maehara
Journal:  J Bacteriol       Date:  2000-07       Impact factor: 3.490

2.  Phage group II staphylococcal strains with chromosomal and extrachromosomal genes for exfoliative toxin production.

Authors:  M Rogolsky; B B Wiley; L A Glasgow
Journal:  Infect Immun       Date:  1976-01       Impact factor: 3.441

3.  Chromosomal synthesis of staphylococcal exfoliative toxin.

Authors:  M Keyhani; M Rogolsky; B B Wiley; L A Glasgow
Journal:  Infect Immun       Date:  1975-07       Impact factor: 3.441

Review 4.  Nonenteric toxins of Staphylococcus aureus.

Authors:  M Rogolsky
Journal:  Microbiol Rev       Date:  1979-09

5.  Purification and characterization of a staphylococcal epidermolytic toxin.

Authors:  R L Dimond; K D Wuepper
Journal:  Infect Immun       Date:  1976-02       Impact factor: 3.441

6.  Production, purification, and chemical characterization of Staphylococcus aureus exfoliative toxin.

Authors:  A D Johnson; J F Metzger; L Spero
Journal:  Infect Immun       Date:  1975-11       Impact factor: 3.441

7.  Detection of anti-exfoliatin antibodies in healthy adults and children by the passive hemagglutination test.

Authors:  Y Sarai; H Nakahara; T Ishikawa; I Kondo; S Futaki
Journal:  Infect Immun       Date:  1977-06       Impact factor: 3.441

8.  Production and properties of a staphylococcin genetically controlled by the staphylococcal plasmid for exfoliative toxin synthesis.

Authors:  M Rogolsky; B B Wiley
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

9.  Identification of the Staphylococcus aureus etd pathogenicity island which encodes a novel exfoliative toxin, ETD, and EDIN-B.

Authors:  Takayuki Yamaguchi; Koji Nishifuji; Megumi Sasaki; Yasuyuki Fudaba; Martin Aepfelbacher; Takashi Takata; Masaru Ohara; Hitoshi Komatsuzawa; Masayuki Amagai; Motoyuki Sugai
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

10.  New type of exfoliatin obtained from staphylococcal strains, belonging to phage groups other than group II, isolated from patients with impetigo and Ritter's disease.

Authors:  I Kondo; S Sakurai; Y Sarai
Journal:  Infect Immun       Date:  1974-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.